Concepedia

Publication | Open Access

Sofosbuvir–velpatasvir in children 3–17 years old with hepatitis C virus infection

DOIFull Paper Access

17

Citations

17

References

2024

Year

Maureen M. Jonas, René Romero, Philip Rosenthal, Chuan‐Hao Lin, Gabriella Verucchi, Jessica Wen, William F. Balistreri, Suzanne Whitworth, Sanjay Bansal, Daniel H. Leung,
Journal of Pediatric Gastroenterology and Nutrition

Abstract

The pangenotypic regimen of sofosbuvir-velpatasvir is highly effective and safe in treating children 3-17 years with chronic HCV infection.

References

YearCitations

Page 1